These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1383297)

  • 1. Epidermal Langerhans cells after allogeneic bone marrow transplantation: depletion by chemotherapy conditioning regimen alone.
    Zambruno G; Girolomoni G; Manca V; Andreani M; Galimberti M; Lucarelli G; Giannetti A
    J Cutan Pathol; 1992 Jun; 19(3):187-92. PubMed ID: 1383297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion and repopulation of epidermal dendritic cells after allogeneic bone marrow transplantation in humans.
    Murphy GF; Merot Y; Tong AK; Smith B; Mihm MC
    J Invest Dermatol; 1985 Mar; 84(3):210-4. PubMed ID: 3919109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
    Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
    Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of thiotepa in allogeneic stem cell transplantation in patients with leukemia.
    Rosales F; Naparstek E; Varadi G; Or R; Slavin S; Nagler A
    Leuk Res; 1999 Oct; 23(10):947-52. PubMed ID: 10573141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of donor-derived Langerhans cells in MHC class II immunodeficient patients after allogeneic bone marrow transplantation.
    Emile JF; Haddad E; Fraitag S; Canioni D; Fischer A; Brousse N
    Br J Haematol; 1997 Aug; 98(2):480-4. PubMed ID: 9266954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation from HLA-identical siblings following conditioning with busulphan and cyclophosphamide.
    Wiktor-Jedrzejczak W; Szczylik C; Matej H; Pojda Z; Ratajczak MZ; Myc A; Siekierzyński M; Kansy J; Kłos M; Rybicki Z
    Arch Immunol Ther Exp (Warsz); 1991; 39(4):441-7. PubMed ID: 1821620
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequential immunohistologic analysis of the skin following allogeneic bone marrow transplantation.
    Volc-Platzer B; Rappersberger K; Mosberger I; Hinterberger W; Emminger-Schmidmeier W; Radaszkiewicz T; Wolff K
    J Invest Dermatol; 1988 Aug; 91(2):162-8. PubMed ID: 3294303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid, parathyroid, gonadal, and pancreatic beta-cell function after bone marrow transplantation with chemotherapy-only conditioning.
    Ghavamzadeh A; Larijani B; Jahani M; Khoshniat M; Bahar B; Tabatabaei O
    Transplant Proc; 2003 Dec; 35(8):3101-4. PubMed ID: 14697989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes.
    Locatelli F; Pession A; Bonetti F; Maserati E; Prete L; Pedrazzoli P; Zecca M; Prete A; Paolucci P; Cazzola M
    Leukemia; 1994 May; 8(5):844-9. PubMed ID: 8182940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD1-reactive leukemic cells in bone marrow: presence of Langerhans cell marker on leukemic monocytic cells.
    Misery L; Campos L; Dezutter-Dambuyant C; Guyotat D; Treille D; Schmitt D; Thivolet J
    Eur J Haematol; 1992 Jan; 48(1):27-32. PubMed ID: 1370420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional development of Langerhans cells and formation of Birbeck granules in human embryonic and fetal skin.
    Fujita M; Furukawa F; Horiguchi Y; Ueda M; Kashihara-Sawami M; Imamura S
    J Invest Dermatol; 1991 Jul; 97(1):65-72. PubMed ID: 1711549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia.
    Kato K; Yoshida N; Matsumoto K; Matsuyama T
    Pediatr Blood Cancer; 2014 Apr; 61(4):712-6. PubMed ID: 24376191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the conditioning regimen on erythrocyte chimerism, graft-versus-host disease and relapse after allogeneic transplantation with lymphocyte depleted marrow.
    Bär BM; Schattenberg A; De Man AJ; Hoogenhout MJ; Boezeman J; de Witte T
    Bone Marrow Transplant; 1992 Jul; 10(1):45-52. PubMed ID: 1515878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation.
    Geller RB; Myers S; Devine S; Larson RA; Williams SF; Park CL; O'Toole K; Chandler C; Topper RL
    Bone Marrow Transplant; 1992 Jan; 9(1):41-7. PubMed ID: 1543948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation following a busulfan-based conditioning regimen in young children with acute lymphoblastic leukemia: a Cooperative Study of the Société Française de Greffe de Moelle.
    von Bueltzingsloewen A; Esperou-Bourdeau H; Souillet G; Demeocq F; Mechinaud-Lacroix F; Michel G; Sadoun A; Bernaudin F; Cornu G; Donadieu J
    Bone Marrow Transplant; 1995 Oct; 16(4):521-7. PubMed ID: 8528167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
    Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In human dermis, ultraviolet radiation induces expansion of a CD36+ CD11b+ CD1- macrophage subset by infiltration and proliferation; CD1+ Langerhans-like dendritic antigen-presenting cells are concomitantly depleted.
    Meunier L; Bata-Csorgo Z; Cooper KD
    J Invest Dermatol; 1995 Dec; 105(6):782-8. PubMed ID: 7490472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.